ArticleThe Lancet. Infectious diseases2022
Endemic mycoses: geographical distribution is still a work in progress - Authors' reply.
Thuy Le, Alessandro C Pasqualotto, George R Thompson
Abstract readLetterComment
In one paragraphArticle in The Lancet. Infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
3 authors.
Thuy LeDivision of Infectious Diseases and International Health, Duke University School of Medicine, Durham, NC, USA.
Alessandro C PasqualottoDepartment of Medicine, Federal University of Health Sciences of Porto Alegre, Porto Alegre, Brazil; Molecular Biology Laboratory, Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Brazil.
George R ThompsonDepartment of Internal Medicine, Division of Infectious Diseases and the Department of Medical Microbiology and Immunology, University of California Davis Medical Center, Sacramento, CA 95817, USA. Electronic address: grthompson@ucdavis.edu.
Funding
Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI Nwora Lance Okeke · 2005 to 2026
$50.5MMaking an early diagnosis of talaromycosis - an approach to reduce morbidity and mortality in advanced HIV disease in Southeast AsiaR01AI143409 · NIAID · DUKE UNIVERSITY · PI LE, THUY · 2019 to 2024
$2.8MTropical Medicine Research Center for Talaromycosis in VietnamU01AI169358 · NIAID · DUKE UNIVERSITY · PI Thuy Le · 2022 to 2026
$2.5MImplications of mycoviral infection in Talaromyces marneffei: an analysis of human patient samples, RNAi, and hypermutationR21AI159397 · NIAID · DUKE UNIVERSITY · PI HEITMAN, JOSEPH, LE, THUY · 2021 to 2022
$443kMapping of the IgM and IgG antibody responses to Talaromyces marneffei infection in mice and humans - Deciphering acute from reactivated or latent infectionsR21AI162367 · NIAID · DUKE UNIVERSITY · PI LE, THUY · 2021 to 2022
$434kNIAID NIH HHS P30 AI064518NIAID NIH HHS R01 AI143409NIAID NIH HHS R21 AI159397NIAID NIH HHS R21 AI162367NIAID NIH HHS U01 AI169358
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
MycosesEndemic DiseasesHumans
Identifiers
PMID35338870
PMCPMC10236952
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390